methotrexate has been researched along with Invasiveness, Neoplasm in 248 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (10.89) | 18.7374 |
| 1990's | 72 (29.03) | 18.2507 |
| 2000's | 72 (29.03) | 29.6817 |
| 2010's | 66 (26.61) | 24.3611 |
| 2020's | 11 (4.44) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, C; Zeng, S; Zhang, Z | 1 |
| Desai, D; Doroszko, M; Eriksson, JE; Kemppainen, K; Niemelä, E; Niemi, R; Özliseli, E; Rahman, NA; Rosenholm, JM; Sahlgren, C; Törnquist, K | 1 |
| Cai, H; Cao, X; Chen, M; Duan, M; Feng, J; Li, J; Wang, W; Yang, C; Zhang, L; Zhang, W; Zhang, Y; Zhou, D; Zhu, T; Zhuang, J | 1 |
| Cheng, X; Lu, W; Lu, Y; Luo, J; Pan, Z; Poon, L; Qin, J; Wang, L; Wu, X; Xie, X; Yu, N; Zhang, S | 1 |
| Audenet, F; Braychenko, E; Elaidi, R; Helali, I; Oudard, S; Rouabah, M; Thibault, C; Vano, YA | 1 |
| Li, X; Liu, Y; Shen, J; Xu, R; Yu, X; Zhang, X | 1 |
| Calò, B; Carrieri, G; Chirico, M; Cormio, L; Falagario, UG; Marchioni, M; Sanguedolce, F | 1 |
| Allory, Y; Culine, S; Fléchon, A; Gravis, G; Guy, L; Harter, V; Joly, F; Laguerre, B; Mottet, N; Pfister, C; Soulié, M | 1 |
| Fukami, N; Fukaya, K; Ichino, M; Kusaka, M; Nukaya, T; Sasaki, H; Shiroki, R; Sumitomo, M; Takahara, K; Takenaka, M; Zennami, K | 1 |
| Cho, YM; Hong, B; Kim, YS; Lee, JL; Lee, Y | 1 |
| Alva, A; Bandini, M; Curran, C; Diamantopoulos, LN; Gallina, A; Grivas, P; Grunewald, CM; Gupta, S; Jain, RK; Lee, JL; McGregor, BA; Mossanen, M; Necchi, A; Niegisch, G; Olson, KM; Pond, GR; Ravi, P; Singh, P; Skelton, WP; Sonpavde, GP; Su, C; Tward, JD | 1 |
| Campbell, M; Czerniak, BA; Dinney, C; Ferguson, JE; Guo, CC; Kamat, AM; Li, R; McConkey, DJ; Metcalfe, MJ; Navai, N; Pretzsch, SM; Siefker-Radtke, A; Xiao, L | 1 |
| Asakuma, J; Asano, T; Hamada, S; Horiguchi, A; Ito, K; Kanbara, T; Tasaki, S; Tsujita, Y; Yoshii, H | 1 |
| Pawar, M; Shah, M; Zawar, V | 1 |
| Liu, H; Tan, Q; Wu, C; Yu, S | 1 |
| Coyle, B; Grundy, RG; Jackson, HK; Kerr, ID; Kilday, JP; Liu, JF; Sabnis, DH; Storer, LCD | 1 |
| Kawamura, N; Matsushita, M; Nin, M; Okada, T; Tsujihata, M; Ujike, T | 1 |
| Asch, AS; Chen, X; Green, T; Ruiz-Echevarría, MJ; Ryan, S | 1 |
| Collins, G; Eyre, T; Hildyard, C; Sheikh, S | 1 |
| Fukami, K; Hirano, T; Kato, A; Kojima, H; Murayama, Y; Nagano, T; Okabe, T; Satow, R; Saya, H; Tamura, M | 1 |
| Izumi, K; Kadono, Y; Kitagawa, Y; Konaka, H; Miwa, S; Mizokami, A; Namiki, M | 1 |
| Datti, A; Egan, SE; Liu, JC; Maclean, N; Robinson, TJ; Schimmer, AD; Sun, T; Vizeacoumar, F; Zacksenhaus, E | 1 |
| Cao, XX; Duan, MH; Li, J; Shen, T; Zhang, W; Zhou, DB | 1 |
| Baggerly, K; Bondaruk, J; Cheng, T; Choi, W; Czerniak, B; Dinney, CP; Hoffman-Censits, J; Kim, S; Lee, IL; Majewski, T; McConkey, DJ; Melquist, J; Plimack, ER; Porten, S; Pretzsch, S; Roth, B; Siefker-Radtke, A; Tran, M; Willis, D; Zhang, S | 1 |
| Abdel-Fatah, TM; Ball, GR; Chan, SY; Ellis, IO; Johnson, C; McArdle, SE; Moseley, PM; Pockley, AG; Rees, RC | 1 |
| Boorjian, SA; Brennan, TA; Chen, DY; Dotan, E; Dulaimi, E; Greenberg, RE; Hoffman-Censits, JH; Hudes, GR; Kelly, WK; Kutikov, A; Lallas, CD; Lin, J; Mehrazin, R; Palma, N; Plimack, ER; Ross, EA; Trabulsi, EJ; Uzzo, RG; Viterbo, R; Wong, YN | 1 |
| Appleman, LJ; Bellmunt, J; Bubley, GJ; Choueiri, TK; Hirsch, M; Jacobus, S; Kantoff, PW; Kibel, AS; Krajewski, KM; Qu, A; Rosenberg, JE; Ross, RW; Signoretti, S; Stack, EC; Steele, G; Sweeney, CJ; Taplin, ME; Tretter, C; Walsh, M | 1 |
| Choi, W; Dinney, CP; McConkey, DJ | 1 |
| Aning, J; Barocas, DA; Bivalacqua, TJ; Black, PC; Campain, NJ; Cookson, MS; Dall'Era, MA; Daneshmand, S; Dinney, CP; Ercole, CE; Espiritu, PN; Fairey, AS; Gandhi, NM; Garcia, JA; Griffin, J; Holzbeierlein, JM; Horenblas, S; Jacobsen, NE; Kassouf, W; Krabbe, LM; Lotan, Y; McGrath, JS; Mertens, LS; Mir, MC; Montgomery, JS; Morgan, TM; North, S; Seah, JA; Shah, JB; Shariat, SF; Spiess, PE; Sridhar, SS; Stephenson, AJ; Thorpe, AC; van Rhijn, BW; Vasdev, N; Wright, JL; Xylinas, E; Youssef, D; Yu, EY; Zargar, H | 1 |
| Xu, M; Xu, S; Yu, X | 1 |
| Cote, RJ; Godoy, G; Groshen, S; Kryvenko, ON; Lerner, SP; Mata, DA; Skinner, DG; Stadler, WM; Stein, JP; von Rundstedt, FC | 1 |
| Ribera, JM; Sancho, JM | 1 |
| Agarwal, N; Bellmunt, J; Berthold, D; Chowdhury, S; Crabb, SJ; Galsky, MD; Harshman, LC; Hussain, SA; Ladoire, S; Milowsky, MI; Moshier, EL; Necchi, A; Pal, SK; Powles, T; Recine, F; Rosenberg, JE; Theodore, C; Vaishampayan, UN; Wong, YN; Yu, EY | 1 |
| Galsky, MD; Sfakianos, JP | 1 |
| Balar, AV; Milowsky, MI | 1 |
| Bagot, M; Beylot-Barry, M; Crickx, B; Deschamps, L; Fite, C; Henn, A; Ingen-Housz-Oro, S; Laroche, L; Marinho, E; Maubec, E; Michel, L; Ortonne, N | 1 |
| Basset, V; Benadiba, S; Chartier, E; Culine, S; Dadoun, D; Desgrandchamps, F; Froger, L; Gauthier, H; Jacob, F; Mongiat-Artus, P; Pashootan, P; Ploussard, G; Ravery, V | 1 |
| Basappa, NS; North, S; Rudzinski, JK | 1 |
| Bergman, AM; Bex, A; Horenblas, S; Kerst, JM; Meijer, RP; Mertens, LS; van de Putte, EE; van der Heijden, MS; van der Poel, HG; van Rhijn, BW | 1 |
| Coquard, R | 1 |
| Cai, Y; Chen, M; Fang, X; He, C; Li, P; Wang, Y; Xiao, F | 1 |
| Jeong, CW; Kim, HH; Kim, HS; Ku, JH; Kwak, C | 1 |
| Gordetsky, JB; Lockhart, ME; Nix, JW; Sonpavde, G | 1 |
| Ali, MS; El-Husseiny, K; Motawei, H | 1 |
| Feng, YI; Gao, X; Ji, J; Ji, KE; Jia, Y; Jiang, WG; Satherley, LK; Shao, S; Sun, PH; Ye, L | 1 |
| Bae, SN; Byun, SW; Park, TC | 1 |
| Alaibac, M; D'Amore, ES; Ferrazzi, A; Russo, I | 1 |
| Kudriavtsev, DV; Kudriavtseva, GT; Mardynskiĭ, IuS | 1 |
| Anthony, CT; Lyons, JM; Thomson, JL; Woltering, EA | 1 |
| Gamal El-Deen, HS | 1 |
| Bajorin, DF; Milowsky, MI; Stadler, WM | 1 |
| Campbell, SC; Dreicer, R; Fergany, AF; Garcia, JA; Gong, MC; Hansel, DE; Jones, JS; Klein, EA; Stephenson, AJ; Weight, CJ | 1 |
| Gorchev, G; Kornovski, Ia; Kozovski, I; Manevska, B; Taskova, V; Trendafilova, E | 1 |
| Arai, A; Iwanaga, Y; Miura, O; Mochizuki, M; Sugamoto, Y; Sugita, S; Takahashi, H; Takase, H; Watanabe, K | 1 |
| Behin, A; Choquet, S; Drouet, T; Guillevin, R; Hoang Xuan, K; Psimaras, D | 1 |
| Brown, RW; Castiglione-Gertsch, M; Coates, AS; Colleoni, M; Crivellari, D; Gelber, RD; Giobbie-Hurder, A; Goldhirsch, A; Golouh, R; Gusterson, BA; Karlsson, P; Maiorano, E; Mallon, E; Mastropasqua, MG; Öhlschlegel, C; Price, KN; Regan, MM; Sonzogni, A; Viale, G | 1 |
| Ahmed, SI; Aleskandarany, MA; Chan, S; Ellis, IO; Elsheikh, SE; Green, AR; Macmillan, RD; Mohammed, RA; Paish, EC; Powe, DG; Rakha, EA | 1 |
| Bellmunt, J; De Santis, M; de Wit, R; Kerst, JM; Leahy, M; Maroto, P; Marreaud, S; Mead, G; Skoneczna, I; Sylvester, R | 1 |
| Bleyer, A; Choi, M; Fuller, CD; Raney, RB; Wang, SJ | 1 |
| Konno, R; Netsu, S; Nokubi, M; Ohmaru, T; Yamakawa, H | 1 |
| Kakimoto, T; Mihara, A; Nakazato, T; Sanada, Y; Suzuki, K; Yoshida, S | 1 |
| Katayama, H; Kato, S; Kawasaki, Y; Mituzuka, K | 1 |
| de Launoit, Y; Dejonghe, MJ; Dessein, AF; Dessein, R; Dumont, P; Figeac, M; Furuichi, Y; Gespach, C; Grard, G; Hebbar, M; Huet, G; Jonckheere, N; Lecellier, CH; Lesuffleur, T; Leteurtre, E; Monté, D; Porchet, N; Prévost, G; Pruvot, FR; Stechly, L; Truant, S | 1 |
| Arai, A; Ishiwata, Y; Miura, O; Mochizuki, M; Nakauchi, Y; Shibata, S; Shibuya, Y; Sugita, S; Takase, H; Yasuhara, M | 1 |
| Aygun, N; Bajaj, G; Fakhry, C; Gillison, M; Westra, W | 1 |
| Al-Muderis, O; Constantinidou, A; Jones, RL; Judson, I; Scurr, M | 1 |
| ElAdl, M; Khalil, S; Maarouf, AM; Nawar, N; Salem, EA; Zaiton, F | 1 |
| Argnani, L; Baccarani, M; Broccoli, A; Derenzini, E; Fanti, S; Gandolfi, L; Pellegrini, C; Quirini, F; Stefoni, V; Zinzani, PL | 1 |
| Song, ST | 1 |
| Brocard, A; Dréno, B; Knol, AC; Peuvrel, L; Quéreux, G; Renaut, JJ | 1 |
| Griffiths, G; Hall, R; Parmar, MK; Raghavan, D; Sylvester, R | 1 |
| Shimada, K | 1 |
| Kaneko, G; Kikuchi, E; Matsumoto, K; Miyajima, A; Nakamura, S; Obata, J; Oya, M | 1 |
| Bari, M; Ciruelos, E; De Benedictis, E; Dittrich, C; Gaion, F; Gomez, P; Lluch, A; Luca, G; Mansutti, M; Morandi, P; Pavesi, L; Semiglazov, V; Valagussa, P; Zamagni, C; Zambetti, M | 1 |
| Cavallin-Stahl, E; Glass, B; Haenel, M; Kaiser, U; Loeffler, M; Pfreundschuh, M; Schmitz, N; Truemper, L; Wolf, M; Zeynalova, S | 1 |
| Malmström, PU; Nilsson, S; Rintala, E; Rosenblatt, R; Sherif, A; Ullén, A; Wahlqvist, R | 1 |
| Badalato, GM; Benson, MC; Hruby, G; McKiernan, JM; Petrylak, DP; RoyChoudhury, A; Wosnitzer, MS; Yeshchina, O | 1 |
| Chen, X; Hu, M; Jiang, X; Lin, Z; Ma, Y; Wang, Q; Wang, Y; Xia, H; Yang, Y | 1 |
| Kim, JJ | 1 |
| Al-Terkait, F; Blick, C; Chester, JD; Crew, J; Douglas, D; Hall, P; Kilbey, N; Macaulay, V; Munro, N; Powles, T; Protheroe, A; Pwint, T | 1 |
| Bagnardi, V; Castiglione-Gertsch, M; Colleoni, M; Dellapasqua, S; Gelber, RD; Goldhirsch, A; Maiorano, E; Mastropasqua, MG; Price, KN; Regan, MM; Rotmensz, N; Viale, G | 1 |
| Li, F; Liu, X; Niu, Z; Wang, L; Wang, X; Wang, Y; Zhang, L | 1 |
| Pal, SK; Ruel, NH; Wilson, TG; Yuh, BE | 1 |
| Bruneau, O; Drouet, A; Guilloton, L; Guyotat, J; Le Moigne, F; Nicolas-Virelizier, E | 1 |
| Kordek, R; Kusinska, R; Majsterek, I; Przybylowska-Sygut, K; Stanczyk, M | 1 |
| Dong, L; He, XD; Shen, ZJ; Tao, SN | 1 |
| Startsev, VY | 1 |
| Cohen, Y; Daas, N; Gillonb, D; Libster, D; Polliack, A | 1 |
| Brundage, M; Chin, JL; Lukka, H; Markman, BR; Segal, R; Winquist, E | 1 |
| Barlebo, H; Colstrup, H; Engelholm, SA; Krarup, T; Lundbeck, F; Madsen, EL; Meyhoff, HH; Mommsen, S; Nielsen, OS; Pedersen, D; Sengeløv, L; Steven, K; Sørensen, B; von der Maase, H | 1 |
| Clippe, C; Clippe, S; Droz, JP; Flechon, A; Yzebe, D | 1 |
| Amini, M; Calabrò, F; De Carli, P; De Paula, F; Emiliozzi, P; Giannarelli, D; Pansadoro, V; Pizzo, M; Platania, A; Scarpone, P; Schnetzer, S; Sternberg, CN | 1 |
| Bisagni, G; Camisa, R; Canaletti, R; Carlini, P; Cocconi, G; Cognetti, F; Di Costanzo, F; Gamboni, A; Gasperoni, S; Porrozzi, S; Pucci, F; Rodinò, C; Ruggeri, EM; Zironi, S | 1 |
| Crawford, ED; deVere White, RW; Grossman, HB; Natale, RB; Raghavan, D; Sarosdy, MF; Speights, VO; Tangen, CM; Trump, DL; Vogelzang, NJ; Wood, DP | 1 |
| Jiraviriyakul, A; Phattarasakul, K; Sutthiphongchai, T; Tohtong, R | 1 |
| Krege, S; Otto, T; Rübben, H; Suhr, J | 1 |
| Habuchi, T; Kamoto, T; Nakashima, M; Nishiyama, H; Ogawa, O; Yagihashi, Y; Yamamoto, S | 1 |
| O'Neill, BP | 1 |
| Harada, T; Terakawa, N; Tsukihara, S | 1 |
| Arai, K; Ema, T; Iwasaki, Y; Katayanagi, S; Maeda, Y; Takahashi, K; Takahashi, T; Yamaguchi, T | 1 |
| Kawaguchi, T; Kumabe, T; Tominaga, T; Watanabe, M | 1 |
| Alzieu, C; Bardou, VJ; Bladou, F; George, L; Gravis, G; Salem, N; Serment, G; Tallet, A | 1 |
| Abe, R; Aoyama, H; Asaga, T; Awane, H; Danno, M; Ikeda, T; Kimura, M; Koyama, H; Mitsuyama, S; Nishi, T; Ogita, M; Sano, M; Takashima, S; Takatsuka, Y; Toi, M; Tominaga, T; Wada, T; Yoshida, M | 1 |
| Bielawski, KP; Bosse, U; Schlotter, CM; Vogt, U | 1 |
| Almog, B; Grisaru, D; Levin, I; Pauzner, D | 1 |
| Aikawa, S; Hatta, Y; Horie, T; Ito, T; Kanbe, E; Kitamura, K; Kura, Y; Oka, H; Saiki, M; Sawada, U; Takeuchi, J; Yamazaki, T | 1 |
| Katz, EE; Krausz, T; Rapp, DE; Sokoloff, MH; Suzue, K; Wille, MA | 1 |
| Fujimoto, K; Fukushima, M; Hirao, Y; Matsui, Y; Nishiyama, H; Ogawa, O; Ohshima, S; Ono, Y; Teramukai, S; Watanabe, J | 1 |
| Raghunadharao, D; Rajappa, S; Rao, IS; Surath, A; Uppin, SG | 1 |
| Bonetti, M; Carbone, A; Castiglione-Gertsch, M; Coates, AS; Collins, J; Crivellari, D; Fey, MF; Gelber, RD; Goldhirsch, A; Golouh, R; Gruber, G; Holmberg, SB; Lindtner, J; Nasi, ML; Price, KN; Rudenstam, CM; Simoncini, E; Thürlimann, B | 1 |
| McLaren, DB | 1 |
| Contreras, L; Gutiérrez, J; Rodríguez, T; Sahid, S; Yazigi, R | 1 |
| Fujioka, H; Honda, M; Matsumiya, K; Satoh, M; Takada, T; Tujimoto, Y | 1 |
| Hirota, S; Kamikonnya, N; Kondoh, N; Maruyama, T; Mori, Y; Nakao, N; Nojima, M; Shima, H; Yamamoto, S | 1 |
| Kitagawa, Y; Nakashima, T; Shigehara, K; Shimamura, M | 1 |
| Aleknavicius, E; Asadauskiene, J; Jankevicius, F; Zelviene, TP | 1 |
| Galanski, M; Lotz, J; Opherk, JP | 1 |
| Géczi, L | 1 |
| Fukuda, H; Higashi, Y; Ichiyanagi, N; Ishioka, J; Kageyama, Y; Nishida, K; Nozu, S; Saito, Y | 1 |
| Akaza, H; Hinotsu, S; Joraku, A; Kawai, K; Miyanaga, N; Oikawa, T; Sekido, N; Shimazui, T | 1 |
| Heidenreich, A | 1 |
| Lantos, G; Revercomb, CH; Warren, FA; Zelefsky, JR | 1 |
| Fukui, I; Katoh, M; Sekine, H; Takeuchi, S; Washizuka, M; Yamada, T; Yokokawa, M | 1 |
| Oliver, RT | 2 |
| Böheim, C; Böheim, K; Mikuz, G | 1 |
| Batley, F; James, AD; Schuller, DE; Smith, RE; Wilson, HE | 1 |
| Brewer, JI; Lurain, JR | 1 |
| Berkowitz, RS; Goldstein, DP | 1 |
| Hiraishi, Y; Kuribayashi, T; Oshima, Y; Shitara, T; Suetake, N | 1 |
| Abe, Y; Asakura, A; Endo, N | 1 |
| Socquet, Y | 2 |
| Bolkenius, M; Brandeis, WE; Daum, R; Roth, H; Schütze, U | 1 |
| Bremer, AM; Hayakawa, T; Mogami, H; Ushio, Y; West, CR; Yamada, K | 1 |
| Chang, LS; Chen, KK; Chen, PM; Chiou, TJ; Hsieh, RK; Wei, CH | 1 |
| Itakura, M; Kobayashi, F; Matsuzaki, S; Muramatsu, C; Onami, S; Sato, T; Shiraishi, K; Simamura, K; Watanabe, M | 1 |
| Scher, HI | 2 |
| Baba, S; Deguchi, N; Miyakawa, A; Murai, M; Nakamura, K; Nakashima, J; Tachibana, M; Tazaki, H | 1 |
| Fujii, A; Gohji, K; Hasunuma, Y; Higuchi, A; Itoh, N; Izumi, T; Maruyama, S; Minayoshi, K; Tanaka, H | 1 |
| Bajorin, DF; Cordon-Cardo, C; Herr, HW; Netto, G; Reuter, VE; Sarkis, AS; Scher, HI; Schultz, PK; Zhang, ZF | 1 |
| Cietak, KA; Kennedy, CR; Walker, DJ | 1 |
| Bárdos, A; Hornák, M; Ondrus, B; Ondrus, D | 1 |
| Cohen, MB; Dreicer, R; Robinson, RA; Sandlow, J; Williams, RD | 1 |
| Chuchkova, M; Damianov, C; Koleva, P; Terziev, T | 1 |
| García Reboll, L; Jiménez Cruz, JF; Martínez Jabaloyas, JM; Pontones Moreno, JL; Ruíz Cerdá, JL; Vera Donoso, CD | 1 |
| Kobayashi, H; Obata, K | 1 |
| Bajorin, DF; Bosl, GJ; Fair, WR; Herr, HW; Sarkis, A; Scher, HI; Scherr, D; Schultz, PK; Seidman, A; Zhang, ZF | 1 |
| Lopez, AE; Lu, Y; Patel, J; Soloway, MS | 1 |
| Herr, HW; Scher, HI | 1 |
| Kietlińska, Z; Sablińska, B; Zieliński, J | 1 |
| Letocha, H; Malmström, PU; Nilsson, S; Rikner, G | 1 |
| Cevoli, R; Cocimano, V; Marino, G; Marten Perolino, R | 1 |
| Simon, SD; Srougi, M | 2 |
| Dreicer, R; Kollmorgen, TA; Smith, RF; Williams, RD | 1 |
| Furukawa, H; Hiratsuka, M; Imaoka, S; Ishikawa, O; Kabuto, T; Kameyama, M; Masutani, S; Nakamori, S; Ohigashi, H; Sasaki, Y | 1 |
| Byhardt, R; Caplan, R; Heaney, J; Shipley, W; Tester, W; True, L; Venner, P; Whittington, R | 1 |
| Freiha, F; Reese, J; Torti, FM | 1 |
| Angulo, JC; Flores, N; Lopez, JI; Sanchez-Chapado, M | 1 |
| Crawford, ED; Einstein, AB; Hafermann, M; Halliday, KR; Leimert, JT; Lowe, BA; Meyers, FJ; Miller, GJ; Wolf, M | 1 |
| Bassot, V; Brasnu, D; Laccourreye, L; Laccourreye, O; Naudo, P; Roux, FX | 1 |
| Kawaguchi, T; Nishimura, S; Takahashi, N | 1 |
| Ayder, AR; Durgun, MN; Lekili, M; Minareci, S; Nergis, S | 1 |
| Donner, G; Flamm, J; Flamm, M; Havelec, L; Lepsinger, L; Ludwig, H; Mayer, A; Oberleitner, S; Sagaster, P | 1 |
| Fujimoto, H; Kakizoe, T; Kume, H; Niwakawa, H; Tobisu, K; Tomita, K; Tsutsumi, M; Yuen, K | 1 |
| Baume, D; Bladou, F; Camerlo, J; Coulange, C; Cowen, D; Gravis, G; Lechevallier, E; Maraninchi, D; Resbeut, M; Serment, G; Viens, P | 1 |
| Kamio, M; Mochizuki, T; Sawada, N; Tanaka, S | 1 |
| Iwasaki, R; Kamano, T; Kobayashi, S; Matsumura, S; Ono, K; Sakamoto, K | 1 |
| Chishima, T; Hoffman, RM; Miyagi, Y; Moossa, AR; Shimada, H; Wang, X; Yamaoka, H | 1 |
| Gates, J; Levine, P; Maiman, M; Mathews, RP; Remy, JC; Serur, E | 1 |
| Asakura, T; Jinza, S; Misaki, H; Nagashima, Y; Satomi, Y; Takase, K | 1 |
| Arias, F; Domínguez, MA; Dueñas, M; Illarramendi, JJ; Martínez, E; Meiriño, R; Molina, F; Tejedor, M; Valerdi, JJ; Villafranca, E | 1 |
| Ambrosini, G; Bolner, A; Caffo, O; Fellin, G; Graffer, U; Luciani, L | 1 |
| Arellano, R; Jiménez, U; López, M; Marín, A; Pérez Torrubia, A; Pinar, B; Zapatero, A | 1 |
| Chadha, M; Grabstald, H; Hecht, H; Malamud, SC; Vikram, B | 1 |
| Falletta, V; Pavone, C; Pavone-Macaluso, M; Piazza, F; Serretta, V; Vasile, P | 1 |
| Bui, BN; Ferrière, JM; Gaston, R; Guillou, ML; Prié, L; Richaud, P | 1 |
| Byrne, MJ; Castiglione-Gertsch, M; Cortés-Funes, H; Ellis, IO; Elston, CW; Gelber, RD; Goldhirsch, A; Golouh, R; Gusterson, BA; Lindtner, J; Murray, S; Pinder, SE; Rudenstam, CM; Simoncini, E; Trihia, H | 1 |
| Doggett, RS; Donnelly, BJ; Heney, NM; Kaufman, DS; Lee, WR; Murray, KJ; Perez, CA; Shipley, WU; Tester, WR; True, LD; Venner, PM; Winter, KA | 1 |
| Hall, RR; Reading, J; Roberts, JT; Thomas, DJ | 1 |
| Chopin, D; Davin, JL; Pariente, JL; Rischmann, P; Theodore, C | 1 |
| Kantoff, PW; Loughlin, KR; Manola, J; Oh, WK; Richie, JP | 1 |
| Dono, K; Eguchi, H; Kishimoto, S; Kondo, M; Miyamoto, A; Monden, M; Nagano, H; Nakamori, S; Nakamura, H; Sakon, M; Shimizu, J; Takeda, Y; Umeshita, K; Wakasa, K | 1 |
| Griffiths, TR; Hall, RR; Lunec, J; Marsh, C; Neal, DE; Qureshi, KN; Roberts, JT; Robinson, MC | 1 |
| Cunningham, DC; Gregory, WM; Hancock, BW; Hoskin, PJ; Linch, DC; Maclennan, KA; Milligan, D; Newland, AC; Smith, P; Stevenson, PA; Vaughan, B; Vaughan, G; Wood, JK | 1 |
| Akaza, H; Akine, Y; Ita, Y; Kawai, K; Kikuchi, K; Miyanaga, N; Ohara, K; Okumura, T; Sekido, N; Shimazui, T; Takeshima, H; Uchida, K | 1 |
| Bagiella, E; Benson, MC; Ennis, RD; O'Toole, KM; Olsson, CA; Petrylak, DP; Singh, P | 1 |
| Lam, WY; Tsui, SH; Wong, MH | 1 |
| Droller, MJ | 3 |
| Akaza, H | 1 |
| Kitaoka, A; Ohsumi, K; Tokuka, A; Tokunaga, Y; Yagi, T | 1 |
| Arellano, R; Cerezo, L; Marín, A; Martín de Vidales, C; Pérez-Torrubia, A; Rabadán, M; Zapatero, A | 1 |
| Natale, RB | 1 |
| Bajorin, DF | 1 |
| Parmar, MK; Sternberg, CN | 1 |
| Chang, SP; Su, WH; Wang, PH | 1 |
| Kageyama, Y; Kihara, K | 1 |
| Barua, J; Bozcuk, H; Gibbs, S; Goonewardene, TI; Mair, G; Nargund, V; Oliver, RT; Philip, T | 1 |
| Otto, T; Rübben, H | 1 |
| Huang, J; Wu, X; Zhang, J | 1 |
| Barbareschi, M; Caffo, O; Dalla Palma, P; Galligioni, E; Kakudo, K; Mauri, F; Mori, I; Muscarà, M; Nakamura, M; Nakamura, Y; Sakurai, T; Yang, Q; Yoshimura, G | 1 |
| Eguchi, T; Hirota, M; Ishii, M; Kanazumi, N; Kato, K; Kimura, J; Kobayashi, H; Suzuki, Y | 1 |
| Anderson, JR; Breneman, JC; Crist, WM; Donaldson, SS; Fitzgerald, TJ; Fryer, CJ; Gehan, EA; Maurer, HM; Meza, J; Michalski, JM; Ortega, JA; Qualman, SJ; Raney, RB; Sandler, E; Wharam, MD; Wiener, ES | 1 |
| Cinieri, S; Colleoni, M; de, BF; Goldhirsch, A; Masci, G; Nolè, F; Orlando, L; Peruzzotti, G; Robertson, C; Rocca, A; Sandri, MT; Viale, G; Zorzino, L | 1 |
| Dembowski, J; Dudek, K; Kolaczyk, W; Lorenz, J | 1 |
| Malicka-Błaszkiewicz, M; Otrocka, M; Verschueren, H | 1 |
| DeAngelis, LM | 1 |
| Akdas, A; Cam, K; Ozveri, H; Turkeri, L; Yildirim, A | 1 |
| Garnick, MB; Mayer, RJ | 1 |
| Bilek, K; Ebeling, K | 1 |
| Büttner, HH; Kyank, H | 1 |
| Betzler, M; Herfarth, C; Schlag, P; Schreml, W | 1 |
| Frykholm, G; Glimelius, B; Hemmingsson, A; Nyman, R; Påhlman, L | 1 |
| Ikeda, Y; Nakazawa, S; Node, Y; Shimura, T | 1 |
| Kamoto, T; Kawakita, M; Matsuda, T; Matsumoto, M; Okabe, T; Yoshida, O | 1 |
| Bukowski, R; Denis, L; Herr, H; Klimberg, I; Scher, HI; Simon, S; Soloway, M; Splinter, TA; van Tinteren, H; Vogelzang, NJ | 1 |
| Boulay, V; Brünner, N; Clarke, R; Leonessa, F; Thompson, EW; Wright, A | 1 |
| Babaya, K; Hirao, Y; Maruyama, Y; Ohara, S; Okajima, E; Ozono, S; Sasaki, K; Watanabe, S; Yamada, K | 1 |
| Asano, K; Kaneko, R; Masuda, F; Suzuki, H; Takamizawa, S | 1 |
| Althausen, AF; Convery, KM; Fung, CY; Griffin, PP; Heney, NM; Kaufman, DS; Prout, GR; Shipley, WU; Young, RH | 1 |
| Hochberg, FH; Loeffler, JS; Prados, M | 1 |
| Fair, WR | 1 |
| Kotake, T | 1 |
| Sternberg, CN | 2 |
| Dumont, R; Guillem, V; Iborra, I; Monrós, JL; Ricós, JV; Solsona, E | 1 |
| Caro Cebrián, C; Gil Sanz, MJ; González Enguita, C; Martínez Bengoechea, J; Rioja Sanz, LA; Roncalés Badal, A | 1 |
| Hall, RR; Parmar, MK | 1 |
| Hahn, RG; Keating, JP; Morgan, WR; Zincke, H | 1 |
| Azab, MB; Boutan-Laroze, A; Court, BH; Droz, JP; Ghosn, M; Ostronoff, M; Perrin, JL; Theodore, C; Travagli, JP; Wibault, P | 1 |
| Bosl, G; Darshaw, D; Fair, W; Herr, H; Morse, M; Reuter, V; Scher, H; Sogani, P; Sternberg, C; Watson, R | 1 |
| Aymé, Y; Berlié, J; Chauvergne, J; Chenal, C; Fargeot, P; George, M; Héron, JF; Lebrun-Jezekova, D; Pigneux, J; Rohart, J | 1 |
| Hiratsuka, H; Kohama, G; Kumagai, S; Miyakawa, A; Yamamoto, E | 1 |
| Adjiman, S; Beuzeboc, P; Boccon-Gibod, L; Steg, A | 1 |
| Bosl, G; Dershaw, D; Fair, W; Herr, H; Morse, M; Reuter, V; Scher, H; Sogani, P; Sternberg, C; Watson, R | 1 |
| Abernathey, CD; Kooistra, KL; Laws, ER; Wilcox, GL | 1 |
| Bavendam, TG; Kramolowsky, EV; Mitros, FA | 1 |
| Chisholm, GD; Elton, RA; Hargreave, TB; Newsam, JE; Smith, G | 1 |
| Fujimoto, T | 1 |
| Dingsør, E; Fosså, SD; Johannessen, NB; Kvarstein, B; Ogreid, P; Stenwig, AE; Urnes, T; Waehre, H | 1 |
| Meyer, JS | 1 |
| Boccon-Gibod, L; Cressey-Kanoui, C; Debré, B; Guinet, F; Steg, A | 1 |
31 review(s) available for methotrexate and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystectomy; Doxorubicin; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Prospective Studies; Retrospective Studies; Urinary Bladder Neoplasms | 2021 |
[Central nervous system relapse in diffuse large B cell lymphoma: Risk factors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast; Central Nervous System; Cyclophosphamide; Doxorubicin; Epidural Space; Female; Genes, myc; Humans; Injections, Spinal; Kidney; L-Lactate Dehydrogenase; Lymphoma, Large B-Cell, Diffuse; Male; Meninges; Methotrexate; Neoplasm Invasiveness; Organ Specificity; Prednisone; Randomized Controlled Trials as Topic; Risk Factors; Rituximab; Testis; Vincristine | 2016 |
Neoadjuvant chemotherapy in the management of muscle-invasive bladder cancer: bridging the gap between evidence and practice.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystectomy; Doxorubicin; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Standard of Care; Urinary Bladder Neoplasms; Vinblastine | 2015 |
Neoadjuvant therapy in muscle-invasive bladder cancer: a model for rational accelerated drug development.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Drug Discovery; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2015 |
Perioperative chemotherapy for muscle invasive bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Humans; Methotrexate; Neoplasm Invasiveness; Palliative Care; Perioperative Period; Urinary Bladder Neoplasms; Vinblastine | 2015 |
Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Cucurbitacins; Docetaxel; Drug Therapy, Combination; Humans; Methotrexate; Molecular Conformation; Neoplasm Invasiveness; Neoplasms; Phytotherapy; Signal Transduction; Structure-Activity Relationship; Taxoids | 2015 |
Pathological T0 Following Cisplatin-Based Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Network Meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Urinary Bladder Neoplasms; Vinblastine | 2016 |
Chemotherapy for Muscle-Invasive Bladder Cancer: Better Late Than Never?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Urinary Bladder Neoplasms; Vinblastine | 2016 |
Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Cystectomy; Doxorubicin; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Prospective Studies; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms | 2008 |
[Annular rectal constriction caused by infiltrating bladder carcinoma: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Signet Ring Cell; Cisplatin; Combined Modality Therapy; Constriction, Pathologic; Cystectomy; Doxorubicin; Fatal Outcome; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasms, Multiple Primary; Rectal Neoplasms; Rectum; Urinary Bladder Neoplasms; Vinblastine | 2010 |
[Treatment strategy for central nervous system involvement in intravascular large B-cell lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Prednisolone; Rituximab; Vascular Neoplasms; Vincristine | 2011 |
Recent advances in treatment of advanced urothelial carcinoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Carcinoma, Transitional Cell; Cetuximab; Cisplatin; Doxorubicin; Female; Gefitinib; Humans; Immunotherapy; Male; Methotrexate; Molecular Targeted Therapy; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Quality Improvement; Quinazolines; Risk Assessment; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2012 |
[A case report of a young patient with invasive bladder cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Humans; Male; Methotrexate; Neoplasm Invasiveness; Prostatic Neoplasms; Urinary Bladder Neoplasms; Urinary Diversion | 2003 |
Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Life Tables; Male; Methotrexate; Middle Aged; Muscle, Smooth; Neoadjuvant Therapy; Neoplasm Invasiveness; Radiotherapy, Adjuvant; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2004 |
Trophoblastic tissue spread to the sigmoid colon after uterine perforation.
Topics: Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Dilatation and Curettage; Female; Follow-Up Studies; Humans; Laparoscopy; Laparotomy; Methotrexate; Neoplasm Invasiveness; Pregnancy; Risk Assessment; Sigmoid Neoplasms; Treatment Outcome; Trophoblastic Neoplasms; Uterine Perforation | 2004 |
Neoadjuvant chemotherapy in transitional-cell carcinoma of the bladder.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Patient Selection; Prognosis; Survival; Urinary Bladder Neoplasms; Vinblastine | 2005 |
[Bladder preservation possibilities in the treatment of muscle-invasive bladder cancer].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cystectomy; Deoxycytidine; Disease-Free Survival; Dose Fractionation, Radiation; Doxorubicin; Gemcitabine; Humans; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Radiation-Sensitizing Agents; Radiotherapy Dosage; Taxoids; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine | 2006 |
[Modern chemotherapy of invasive bladder cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Lymphatic Metastasis; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Paclitaxel; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2007 |
[A case of retroperitoneal NHL with direct invasion to the liver, pancreas and gastric wall].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Humans; Leucovorin; Liver Neoplasms; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Invasiveness; Pancreatic Neoplasms; Prednisone; Remission Induction; Retroperitoneal Neoplasms; Stomach Neoplasms; Vincristine | 1995 |
[Place of chemotherapy in the treatment of invasive bladder tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Humans; Methotrexate; Neoplasm Invasiveness; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1999 |
Burkitt's lymphoma presenting as mandibular swelling--report of a case and review of publications.
Topics: Antimetabolites, Antineoplastic; Burkitt Lymphoma; Child, Preschool; Diagnosis, Differential; Humans; Injections, Spinal; Male; Mandibular Neoplasms; Maxillary Sinus Neoplasms; Methotrexate; Neoplasm Invasiveness; Radiography | 2000 |
Advances in chemotherapy of invasive bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Urinary Bladder Neoplasms; Vinblastine | 2000 |
Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Doxorubicin; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Radiotherapy, Adjuvant; Reproducibility of Results; Research Design; Urinary Bladder Neoplasms; Vinblastine | 2000 |
[Neoadjuvant chemotherapy for invasive bladder cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystectomy; Doxorubicin; Drug Administration Schedule; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Postoperative Care; Randomized Controlled Trials as Topic; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 2001 |
Primary central nervous system lymphomas.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Combined Modality Therapy; Contraindications; Cranial Irradiation; Craniotomy; Diagnostic Imaging; Eye; Humans; Injections, Spinal; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Meninges; Methotrexate; Middle Aged; Neoplasm Invasiveness; Seizures; Stereotaxic Techniques; Survival Analysis; Treatment Outcome; Vitrectomy | 2001 |
[Clinical aspects of trophoblastic tumors].
Topics: Choriocarcinoma; Chorionic Gonadotropin; Dactinomycin; Drug Therapy, Combination; Female; Humans; Mercaptopurine; Methotrexate; Neoplasm Invasiveness; Neoplasm Metastasis; Pregnancy; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms | 1978 |
The biology of breast tumor progression. Acquisition of hormone independence and resistance to cytotoxic drugs.
Topics: Animals; Breast Neoplasms; Colchicine; Drug Resistance; Female; Gene Expression Regulation, Neoplastic; Humans; Methotrexate; Mice; Mice, Nude; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Phenotype; Tumor Cells, Cultured | 1992 |
The therapy of primary brain lymphoma.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Evaluation Studies as Topic; Eye Neoplasms; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Life Tables; Lymphoma, Non-Hodgkin; Meningeal Neoplasms; Methotrexate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Radiotherapy; Spinal Neoplasms; Survival Rate; Transplantation | 1991 |
[Chemotherapy in the treatment of advanced urothelial tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Hematopoietic Cell Growth Factors; Humans; Methotrexate; Neoplasm Invasiveness; Neoplasm Metastasis; Randomized Controlled Trials as Topic; Urinary Bladder Neoplasms; Vinblastine | 1991 |
Neo-adjuvant M-VAC (methotrexate, vinblastine, adriamycin, and cisplatin) for infiltrating bladder cancer: initial results in Italy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Humans; Italy; Methotrexate; Neoplasm Invasiveness; Urinary Bladder Neoplasms; Vinblastine | 1990 |
[Randomized trial of initial chemotherapy in 151 locally advanced carcinoma of the cervix (T2b-N1, T3b, MO)].
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chlorambucil; Cisplatin; Combined Modality Therapy; Female; Humans; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prospective Studies; Radiotherapy Dosage; Survival Rate; Uterine Cervical Neoplasms; Vincristine | 1990 |
50 trial(s) available for methotrexate and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Open-label phase II to evaluate the efficacy of NEoadjuvant dose-dense MVAC In cOmbination with durvalumab and tremelimumab in muscle-invasive urothelial carcinoma: NEMIO.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials, Phase II as Topic; Doxorubicin; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2020 |
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Seconda
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Perioperative Period; Prospective Studies; Urinary Bladder Neoplasms; Vinblastine | 2021 |
Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blotting, Western; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Differentiation; Cell Proliferation; Cisplatin; Clinical Trials, Phase II as Topic; Cohort Studies; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Humans; Male; Methotrexate; MicroRNAs; Muscle Neoplasms; Mutation; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; PPAR gamma; Prognosis; Real-Time Polymerase Chain Reaction; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms; Vinblastine | 2014 |
Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Fatigue; Female; Filgrastim; Gene Expression Profiling; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Polyethylene Glycols; Prospective Studies; Protective Agents; Recombinant Proteins; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2014 |
Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease-Free Survival; DNA-Binding Proteins; Doxorubicin; Drug Administration Schedule; Endonucleases; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Polyethylene Glycols; Protective Agents; Radiography; Recombinant Proteins; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2014 |
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease Progression; Female; Fluorouracil; Goserelin; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Predictive Value of Tests; Prognosis; Treatment Outcome | 2010 |
Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Survival Analysis; Treatment Outcome; Urologic Neoplasms; Urothelium; Vinblastine | 2009 |
International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Female; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Urinary Bladder Neoplasms; Vinblastine | 2011 |
Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II).
Topics: Adult; Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Cyclophosphamide; Deoxycytidine; Doxorubicin; Female; Fluorouracil; Humans; Leukopenia; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm, Residual; Neutropenia; Paclitaxel; Receptors, Estrogen; Treatment Outcome | 2012 |
Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Creatinine; Cystectomy; Disease-Free Survival; Female; Humans; Leucovorin; Life Tables; Male; Methotrexate; Middle Aged; Muscle, Smooth; Neoadjuvant Therapy; Neoplasm Invasiveness; Prospective Studies; Radiotherapy, High-Energy; Survival Analysis; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms | 2002 |
Can patient selection for bladder preservation be based on response to chemotherapy?
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Patient Selection; Urinary Bladder Neoplasms; Vinblastine | 2003 |
Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Confidence Intervals; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Italy; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Probability; Prognosis; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 2003 |
Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Analysis; Urinary Bladder Neoplasms; Vinblastine | 2003 |
1-hexylcarbamoyl-5-fluorouracil + cyclophosphamide + tamoxifen versus CMF + tamoxifen in women with lymph node-positive breast cancer after primary surgery: a randomized controlled trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Survival Rate; Tamoxifen | 2004 |
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Ca
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Postmenopause; Prognosis; Retrospective Studies | 2005 |
[Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radiotherapy Dosage; Urinary Bladder Neoplasms; Vinblastine | 2006 |
Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Risk Factors; Time Factors; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1996 |
[Clinical efficacy of methotrexate, vinblastine, doxorubicin and cisplatin adjuvant chemotherapy following radical surgery for locally invasive urothelial cancers: long-term results].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Postoperative Care; Prognosis; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1995 |
Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Analysis; Urinary Bladder Neoplasms; Vincristine | 1993 |
Systemic chemotherapy for muscle invasive bladder cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Combined immunochemotherapy (CEP, M-VEP + BCG) in the treatment of invasive bladder tumors.
Topics: Administration, Intravesical; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Immunotherapy, Active; Lomustine; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prednimustine; Urinary Bladder Neoplasms; Vinblastine | 1994 |
[Neo-adjuvant M-VAC in the treatment of infiltrating bladder tumors].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Results of adjuvant chemotherapy for invasive urothelial cancer with lymph-node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Kidney Neoplasms; Kidney Pelvis; Longitudinal Studies; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Rate; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1994 |
Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Survival Analysis; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Combined systemic chemotherapy and irradiation of muscle-invasive transitional cell carcinoma of the urinary bladder.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Humans; Injections, Intramuscular; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Radiotherapy Dosage; Remission Induction; Treatment Outcome; Urinary Bladder Neoplasms | 1994 |
Primary methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and bladder preservation in locally invasive bladder cancer: a 5-year followup.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Remission Induction; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy; Salvage Therapy; Survival Analysis; Treatment Failure; Urinary Bladder Neoplasms; Vinblastine | 1996 |
A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Muscle, Smooth; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Prospective Studies; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Methotrexate; Multivariate Analysis; Neoplasm Invasiveness; Prognosis; Proportional Hazards Models; Time Factors; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: a phase I/II Southwestern Oncology Group study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Radiotherapy, Adjuvant; Remission Induction; Surgical Procedures, Operative; Survival Rate; Urethra; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Conservative management of advanced bladder cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Survival Analysis; Urinary Bladder Neoplasms; Vinblastine | 1995 |
Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Infections; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neutropenia; Recombinant Proteins; Stomatitis; Thrombocytopenia; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Survival Rate; Uterine Cervical Neoplasms | 1997 |
Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prospective Studies; Survival Analysis; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 1997 |
Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Neoplasm Invasiveness; Pilot Projects; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 1998 |
The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Estrogen Antagonists; Female; Fluorouracil; Forecasting; Humans; Lymph Nodes; Mastectomy; Methotrexate; Neoplasm Invasiveness; Postmenopause; Prednisone; Premenopause; Prognosis; Proportional Hazards Models; Survival Rate; Tamoxifen | 1998 |
Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Hematologic Diseases; Humans; Male; Methotrexate; Middle Aged; Nausea; Neoplasm Invasiveness; Survival Analysis; Time Factors; Urinary Bladder Neoplasms; Vinblastine | 1998 |
Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Australia; Canada; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Europe; Female; Humans; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 1999 |
A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Humans; Kidney Neoplasms; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Survival Rate; Urinary Bladder Neoplasms | 1999 |
A randomized British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prednisolone; Severity of Illness Index; Survival Analysis; United Kingdom; Vincristine | 2000 |
A bladder preservation regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer: a prospective study.
Topics: Aged; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Female; Humans; Injections, Intra-Arterial; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Treatment Failure; Urinary Bladder Neoplasms | 2000 |
Phase 1/2 study of synchronous methotrexate, cisplatin, vincristine (MOPq10) chemotherapy and radiation for patients with locally advanced bladder cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystoscopy; Disease-Free Survival; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Treatment Outcome; Urinary Bladder Neoplasms; Vincristine | 2001 |
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Endothelial Growth Factors; Female; Humans; Lymphokines; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
[Current status of adjuvant chemotherapy of invasive bladder cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Phosphoramide Mustards; Urinary Bladder Neoplasms; Vinblastine | 1991 |
Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Epidemiologic Methods; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prognosis; Prospective Studies; Surgical Procedures, Operative; Urinary Bladder Neoplasms; Vinblastine | 1991 |
[Stage T4 bladder cancer. Impact of neoadjuvant chemotherapy on T4b tumors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Survival Rate; Urinary Bladder Neoplasms; Urinary Diversion; Vinblastine | 1990 |
[Neoadjuvant chemotherapy (M-VAC) in invasive cancer of the bladder. Our experience].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Drug Evaluation; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 1990 |
Randomised intercontinental trial of locoregional therapy with or without neoadjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Humans; International Cooperation; Methotrexate; Muscles; Neoplasm Invasiveness; Quality Control; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1990 |
[Randomized trial of initial chemotherapy in 151 locally advanced carcinoma of the cervix (T2b-N1, T3b, MO)].
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chlorambucil; Cisplatin; Combined Modality Therapy; Female; Humans; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prospective Studies; Radiotherapy Dosage; Survival Rate; Uterine Cervical Neoplasms; Vincristine | 1990 |
[Infiltrating tumors of the bladder. Local response to systemic platinum-based chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Organoplatinum Compounds; Urinary Bladder Neoplasms; Vinblastine | 1989 |
168 other study(ies) available for methotrexate and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin as the Gold Standard Neoadjuvant Chemotherapy Regimen for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer Remains Controversial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystectomy; Doxorubicin; Humans; Methotrexate; Muscles; Neoadjuvant Therapy; Neoplasm Invasiveness; Urinary Bladder Neoplasms; Vinblastine | 2022 |
Nanoparticles carrying fingolimod and methotrexate enables targeted induction of apoptosis and immobilization of invasive thyroid cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Drug Delivery Systems; Fingolimod Hydrochloride; Folate Receptors, GPI-Anchored; Humans; Methotrexate; Nanoparticles; Neoplasm Invasiveness; Silicon Dioxide; Thyroid Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Intravenous methotrexate at a dose of 1 g/m
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cerebrospinal Fluid; Chemical and Drug Induced Liver Injury; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Kidney Diseases; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mucositis; Neoplasm Invasiveness; Prednisone; Proportional Hazards Models; Prospective Studies; Recurrence; Rituximab; Vincristine | 2020 |
Doppler-based predictive model for methotrexate resistance in low-risk gestational trophoblastic neoplasia with myometrial invasion: prospective study of 147 patients.
Topics: Adult; Antimetabolites, Antineoplastic; Drug Resistance, Neoplasm; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Myometrium; Neoplasm Invasiveness; Predictive Value of Tests; Pregnancy; Prospective Studies; Ultrasonography, Doppler; Ultrasonography, Prenatal | 2021 |
Circular RNA hsa_circ_0000073 contributes to osteosarcoma cell proliferation, migration, invasion and methotrexate resistance by sponging miR-145-5p and miR-151-3p and upregulating NRAS.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; GTP Phosphohydrolases; Humans; Membrane Proteins; Methotrexate; MicroRNAs; Neoplasm Invasiveness; Osteosarcoma; RNA, Circular | 2020 |
Two cycles of neoadjuvant chemotherapy improves survival in patients with high-risk upper tract urothelial carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Kidney Neoplasms; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Nephroureterectomy; Proportional Hazards Models; Retrospective Studies; Sex Factors; Survival Rate; Ureteral Neoplasms; Vinblastine | 2021 |
Comparison of clinical outcomes in patients with localized or locally advanced urothelial carcinoma treated with neoadjuvant chemotherapy involving gemcitabine-cisplatin and high dose-intensity MVAC.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 2021 |
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Internationality; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Muscle, Smooth; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Risk Factors; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine | 2021 |
Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease-Free Survival; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mucous Membrane; Muscle Neoplasms; Neoplasm Invasiveness; Preoperative Care; Risk Factors; Urinary Bladder Neoplasms; Vinblastine | 2017 |
[A CASE OF METASTATIC BLADDER UROTHELIAL CARCINOMA WHOSE DISEASE WAS CONTROLLED FOR A RELATIVE LONG PERIOD BY MULTIDISCIPLINARY TREATMENT INCLUDING RADIATION TO A LUNG METASTASIS AND MULTIPLE COURSES OF CHEMOTHERAPY].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Carcinoma; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Doxorubicin; Fatal Outcome; Female; Humans; Infusions, Intra-Arterial; Kidney Neoplasms; Kidney Pelvis; Liver Neoplasms; Lung Neoplasms; Methotrexate; Neoplasm Invasiveness; Organ Sparing Treatments; Time Factors; Ureteral Neoplasms; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine | 2017 |
A rare and isolated presentation of primary cutaneous anaplastic large cell lymphoma.
Topics: Administration, Oral; Adolescent; Biopsy, Needle; Humans; Immunohistochemistry; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Male; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Rare Diseases; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2018 |
Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Choriocarcinoma; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Inhibitory Concentration 50; Methotrexate; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Long Noncoding; Signal Transduction; TOR Serine-Threonine Kinases; Wound Healing | 2019 |
A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma.
Topics: ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Child, Preschool; Drug Resistance, Neoplasm; Drug Synergism; Ependymoma; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Infant; Methotrexate; Neoplasm Invasiveness; Neoplastic Stem Cells; Prognosis; Survival Analysis; Up-Regulation; Vardenafil Dihydrochloride; Verapamil; Vincristine | 2019 |
[Relative efficacy of neoadjuvant gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management for muscle-invasive bladder cancer].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Retrospective Studies; Urinary Bladder Neoplasms; Vinblastine | 2013 |
TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells.
Topics: Antimetabolites, Antineoplastic; Carbon; Cell Proliferation; Cell Transformation, Neoplastic; Gene Knockdown Techniques; Humans; Male; Membrane Proteins; Methotrexate; Neoplasm Invasiveness; Neoplasm Proteins; Prostate; Prostatic Neoplasms; Sarcosine; Sarcosine Dehydrogenase; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2013 |
Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Cerebrospinal Fluid; Dexamethasone; Etoposide; Female; Headache; Humans; Ifosfamide; Lumbar Vertebrae; Lymphoma, Extranodal NK-T-Cell; Magnetic Resonance Imaging; Methotrexate; Neoplasm Invasiveness; Pia Mater; Polyradiculopathy | 2013 |
Identification of novel small compounds that restore E-cadherin expression and inhibit tumor cell motility and invasiveness.
Topics: Adenocarcinoma; Antineoplastic Agents; Cadherins; Cell Line; Cell Line, Tumor; Cell Movement; Cell Survival; Colorectal Neoplasms; Drug Screening Assays, Antitumor; High-Throughput Screening Assays; Humans; Melanoma; Methotrexate; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Proto-Oncogene Proteins c-akt; Small Molecule Libraries | 2013 |
Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Disease-Free Survival; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2013 |
RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugs.
Topics: Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Gamma Rays; Humans; Methotrexate; Neoplasm Invasiveness; Neoplastic Stem Cells; Oligonucleotide Array Sequence Analysis; Pharmacogenetics; Retinoblastoma Protein; Treatment Outcome; Triple Negative Breast Neoplasms | 2013 |
Patients with primary diffuse large B-cell lymphoma of female genital tract have high risk of central nervous system relapse.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Genitalia, Female; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prednisone; Prognosis; Recurrence; Retrospective Studies; Rituximab; Vincristine; Young Adult | 2014 |
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Cyclophosphamide; DEAD-box RNA Helicases; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Lymphocytes, Tumor-Infiltrating; Mastectomy; Menopause; Methotrexate; Mitotic Index; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Prognosis; Proportional Hazards Models; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Treatment Outcome | 2014 |
New insights into subtypes of invasive bladder cancer: considerations of the clinician.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Methotrexate; Microarray Analysis; Molecular Targeted Therapy; Muscle, Smooth; Neoplasm Invasiveness; Prognosis; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2014 |
Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Doxorubicin; Europe; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; North America; Odds Ratio; Proportional Hazards Models; Retrospective Studies; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2015 |
Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Prognosis; Survival Rate; Time Factors | 2014 |
Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Methotrexate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium; Vinblastine | 2015 |
Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Muscle Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2015 |
Sézary syndrome without erythroderma.
Topics: Administration, Topical; Adrenal Cortex Hormones; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Combined Modality Therapy; Dermatitis, Exfoliative; Female; Follow-Up Studies; France; Humans; Immunohistochemistry; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Photopheresis; Rare Diseases; Retrospective Studies; Risk Assessment; Sampling Studies; Sex Factors; Sezary Syndrome; Skin Neoplasms | 2015 |
[Neoadjuvant chemotherapy in muscular invasive bladder cancer: Complications and consequences with cystectomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Postoperative Complications; Retrospective Studies; Urinary Bladder Neoplasms; Vinblastine | 2015 |
Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Retrospective Studies; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2016 |
[Neoadjuvant chemotherapy with MVAC in bladder carcinoma: Is the feasibility really established? Of: Benadiba et al.: Neoadjuvant chemotherapy in muscular invasive bladder cancer: Complications and consequences on cystectomy, Pr Urol 2015; 25: 549-554].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Urinary Bladder Neoplasms; Vinblastine | 2015 |
Singapore Cancer Network (SCAN) Guidelines for Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Methotrexate; Muscle, Smooth; Neoadjuvant Therapy; Neoplasm Invasiveness; Singapore; Urinary Bladder Neoplasms; Vinblastine | 2015 |
Continuous Low-Dose Oral Cyclophosphamide and Methotrexate as Maintenance Therapy in Patients With Advanced Ovarian Carcinoma After Complete Clinical Response to Platinum and Paclitaxel Chemotherapy.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Remission Induction; Survival Rate | 2016 |
Reduced RanBPM Expression Is Associated with Distant Metastasis in Gastric Cancer and Chemoresistance.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Antimetabolites, Antineoplastic; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Cytoskeletal Proteins; Down-Regulation; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Methotrexate; Neoplasm Invasiveness; Nuclear Proteins; RNA, Catalytic; Signal Transduction; Stomach Neoplasms; Time Factors; Transfection | 2016 |
Conservative Chemotherapy in Gestational Trophoblastic Disease: Experience With Etoposide, Methotrexate, and Dactinomycin Chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Pregnancy; Prognosis; Salvage Therapy | 2016 |
A Case of Angioinvasive Cutaneous Anaplastic Large Cell Lymphoma Completely Regressed After Low-dose Systemic Methotrexate.
Topics: Aged; Antimetabolites, Antineoplastic; Blood Vessels; Female; Humans; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Neoplasm Invasiveness; Skin Neoplasms | 2017 |
[Adjuvant chemotherapy as a component of complex treatment for skin melanoma].
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Lymph Node Excision; Male; Melanoma; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Radiotherapy, Adjuvant; Skin Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2008 |
A novel assay to assess the effectiveness of antiangiogenic drugs in human breast cancer.
Topics: Angiogenesis Inhibitors; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Biological Assay; Blood Coagulation; Breast Neoplasms; Doxorubicin; Drug Screening Assays, Antitumor; Female; Fibrin; Fluorouracil; Humans; Methotrexate; Neoplasm Invasiveness; Neovascularization, Pathologic; Paclitaxel; Thrombin; Vincristine | 2008 |
Initial results of retrospective study: preoperative transurethral excision plus chemotherapy and radiation therapy and trial of bladder preservation.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Preoperative Care; Prognosis; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2007 |
Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Combined Modality Therapy; Cystectomy; Deoxycytidine; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Maximum Tolerated Dose; Methotrexate; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Risk Factors; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2009 |
[Successful treatment of locally invasive, nonmetastatic choriocarcinoma after ectopic pregnancy by monochemotherapy].
Topics: Adult; Antimetabolites, Antineoplastic; Choriocarcinoma; Disease-Free Survival; Female; Humans; Methotrexate; Neoplasm Invasiveness; Pregnancy; Pregnancy, Ectopic; Treatment Outcome; Uterine Neoplasms | 2008 |
[Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
Topics: Brain Neoplasms; Eye Neoplasms; Fatal Outcome; Frontal Lobe; Humans; Injections, Intralesional; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Vitreous Body | 2009 |
[Bing-Neel syndrome revealing Waldenström's macroglobulinemia].
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone and Bones; Central Nervous System Diseases; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Magnetic Resonance Imaging; Male; Meningitis; Methotrexate; Middle Aged; Neoplasm Invasiveness; Nervous System Neoplasms; Polyradiculopathy; Prednisone; Rituximab; Spinal Nerve Roots; Syndrome; Vincristine; Waldenstrom Macroglobulinemia | 2010 |
Growth fraction as a predictor of response to chemotherapy in node-negative breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Lymph Nodes; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Survival Rate; Treatment Outcome | 2010 |
Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dacarbazine; Dactinomycin; Etoposide; Female; Humans; Hydrocortisone; Injections, Spinal; Male; Meninges; Methotrexate; Myelitis; Neoplasm Invasiveness; Puberty; Radiation Injuries; Retrospective Studies; Rhabdomyosarcoma; Sarcoma, Ewing; Spinal Cord; Spinal Neoplasms; Vincristine | 2009 |
Placental site trophoblastic tumor (PSTT) with multiple metastases and extremely poor prognosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cell Differentiation; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Humans; Magnetic Resonance Imaging; Methotrexate; Mitotic Index; Neoplasm Invasiveness; Pregnancy; Tomography, X-Ray Computed; Treatment Failure; Trophoblastic Tumor, Placental Site; Uterine Neoplasms; Vincristine | 2009 |
[Intravascular large B-cell lymphoma with pontine involvement successfully treated with R-hyper-CVAD/R-MTX-Ara-C regimen].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Neoplasm Invasiveness; Remission Induction; Treatment Outcome; Vascular Neoplasms; Vincristine | 2010 |
Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells.
Topics: Animals; Colonic Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Profiling; Gene Silencing; HT29 Cells; Humans; Intramolecular Oxidoreductases; Macrophage Migration-Inhibitory Factors; Methotrexate; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Phenotype; Receptors, CXCR4; Signal Transduction; Up-Regulation | 2010 |
Concurrent administration of intravenous systemic and intravitreal methotrexate for intraocular lymphoma with central nervous system involvement.
Topics: Aged; Antimetabolites, Antineoplastic; Central Nervous System Neoplasms; Drug Administration Routes; Eye Neoplasms; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Invasiveness; Treatment Outcome | 2010 |
Long-term survival of a patient with leptomeningeal involvement by nasopharyngeal carcinoma after treatment with high-dose intravenous methotrexate.
Topics: Adult; Antimetabolites, Antineoplastic; Cisplatin; Fluorouracil; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Meningeal Carcinomatosis; Methotrexate; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Radiotherapy Dosage | 2012 |
Advanced aggressive fibromatosis: Effective palliation with chemotherapy.
Topics: Abdominal Neoplasms; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease Progression; Doxorubicin; Female; Fibromatosis, Aggressive; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Palliative Care; Polyethylene Glycols; Radiography; Registries; Retrospective Studies; Treatment Outcome; Vinblastine; Young Adult | 2011 |
Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Epidemiologic Methods; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2011 |
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Monitoring, Physiologic; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Retrospective Studies; Rituximab; Survival Analysis; Time Factors; Vincristine; Young Adult | 2011 |
[Practice and consideration on neoadjuvant therapy for early breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tumor Burden | 2010 |
Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants.
Topics: Adult; Antibiotics, Antineoplastic; Biopsy; Cyclosporine; Doxorubicin; Etanercept; Fatal Outcome; Humans; Immunoglobulin G; Immunosuppressive Agents; Leg; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Polyethylene Glycols; Psoriasis; Receptors, Tumor Necrosis Factor; Skin Neoplasms; Treatment Failure | 2010 |
Neoadjuvant gemcitabine plus cisplatin for muscle-invasive bladder cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystectomy; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Muscle, Smooth; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2011 |
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Topics: Adolescent; Adult; Age of Onset; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany; Humans; International Cooperation; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Medical Oncology; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Grading; Neoplasm Invasiveness; Prednisolone; Prednisone; Rituximab; Societies, Medical; Vincristine; Young Adult | 2012 |
Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Cystectomy; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Multivariate Analysis; Muscle, Smooth; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Scandinavian and Nordic Countries; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium | 2012 |
Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Deoxycytidine; Doxorubicin; Drug Evaluation; Female; Follow-Up Studies; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Proportional Hazards Models; Retrospective Studies; Urinary Bladder Neoplasms; Vinblastine | 2012 |
Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasis.
Topics: Active Transport, Cell Nucleus; Antimetabolites, Antineoplastic; beta Catenin; Cadherins; Cell Adhesion; Cell Movement; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Fluorouracil; Gene Knockdown Techniques; HCT116 Cells; HT29 Cells; Humans; Liver Neoplasms; Methotrexate; Neoplasm Invasiveness; Transcription, Genetic | 2012 |
Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Neoadjuvant Therapy; Neoplasm Invasiveness; Recurrence; Retrospective Studies; Urinary Bladder Neoplasms; Vinblastine | 2012 |
A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Decision Support Techniques; Female; Fluorouracil; Goserelin; Humans; Ki-67 Antigen; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplasm Metastasis; Nomograms; Premenopause; Randomized Controlled Trials as Topic; Receptors, Estrogen; Risk Assessment; Survival Analysis; Tamoxifen; Treatment Outcome; Tumor Burden | 2012 |
Clinicopathological significance of mesothelin expression in invasive breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; GPI-Linked Proteins; Humans; Immunohistochemistry; Lymphatic Metastasis; Mesothelin; Methotrexate; Neoplasm Invasiveness; Paraffin Embedding; Radiotherapy; Receptor, ErbB-3; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies | 2012 |
Retrospective analysis of clinical outcomes with neoadjuvant cisplatin-based regimens for muscle-invasive bladder cancer.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Muscle, Smooth; Neoadjuvant Therapy; Neoplasm Invasiveness; Retrospective Studies; Survival Analysis; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine | 2012 |
[Occipital neuralgia (Arnold) as the presenting symptom of diffuse large B-cell non-Hodgkin lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cervical Vertebrae; Cyclophosphamide; Doxorubicin; Female; Head and Neck Neoplasms; Humans; Hypesthesia; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Neck Pain; Neoplasm Invasiveness; Neuralgia; Positron-Emission Tomography; Prednisolone; Rituximab; Spinal Cord Compression; Vincristine | 2013 |
Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; DNA Repair; DNA-Binding Proteins; Doxorubicin; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Immunoenzyme Techniques; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Risk Factors; Survival Rate; X-ray Repair Cross Complementing Protein 1 | 2013 |
[Differential invasion and metastasis capacities of methotrexate enantiomer-resistant A549 cell lines].
Topics: Cell Line, Tumor; Cell Movement; Drug Resistance, Neoplasm; Humans; Methotrexate; Neoplasm Invasiveness | 2012 |
The role of combined method in organ-sparing treatment of muscle-invasive bladder cancer recurrences.
Topics: Aged; BCG Vaccine; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Disease Progression; Doxorubicin; Female; Humans; Life Tables; Male; Methotrexate; Middle Aged; Muscle, Smooth; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Radiotherapy, High-Energy; Remission Induction; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2002 |
Large B-cell lymphoma manifesting as an invasive cardiac mass: sustained local remission after combination of methotrexate and rituximab.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Female; Heart Neoplasms; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Invasiveness; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Transplantation, Autologous | 2002 |
Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cystectomy; Doxorubicin; Epirubicin; Evidence-Based Medicine; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Invasiveness; Randomized Controlled Trials as Topic; Survival Analysis; Urinary Bladder Neoplasms; Vinblastine | 2002 |
[Bladder cancer chemotherapy practice study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Humans; Methotrexate; Neoplasm Invasiveness; Neoplasm Metastasis; Retrospective Studies; Time Factors; Urinary Bladder Neoplasms; Vinblastine | 2002 |
Dependence of metastatic cancer cell invasion on MLCK-catalyzed phosphorylation of myosin regulatory light chain.
Topics: Adenocarcinoma; Animals; Azepines; Cell Division; Cell Line, Tumor; Cell Movement; Dose-Response Relationship, Drug; Male; Methotrexate; Myosin Light Chains; Myosin-Light-Chain Kinase; Naphthalenes; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Prostatic Neoplasms; Rats | 2003 |
[Therapy of advanced penis carcinoma].
Topics: Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Graft Survival; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Microsurgery; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Penile Neoplasms; Skin; Superinfection; Surgical Flaps; Surgical Wound Infection; Suture Techniques; Treatment Outcome; Wound Healing | 2003 |
Neurocognitive outcomes in primary CNS lymphoma (PCNSL).
Topics: Aged; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Comorbidity; Cranial Irradiation; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Neoplasm Invasiveness; Radiation Injuries; Treatment Outcome | 2004 |
Ultrasound-guided local injection of methotrexate to treat an invasive hydatidiform mole.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Diagnosis, Differential; Female; Gravidity; Humans; Hydatidiform Mole; Injections, Intralesional; Methotrexate; Neoplasm Invasiveness; Pregnancy; Ultrasonography, Interventional; Uterine Neoplasms | 2004 |
[A case of curatively resected gastric cancer through an effective response to chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Fluorouracil; Gastrectomy; Humans; Jejunostomy; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Pancreatic Neoplasms; Peritoneal Neoplasms; Quality of Life; Stomach Neoplasms | 2004 |
Atypical teratoid/rhabdoid tumour with leptomeningeal dissemination in an adult.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Methotrexate; Neoplasm Invasiveness; Rhabdoid Tumor; Teratoma | 2004 |
Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cyclophosphamide; Diphosphonates; Docetaxel; Drug Synergism; Epirubicin; Female; Fluorouracil; Humans; Ibandronic Acid; Imidazoles; In Vitro Techniques; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasms, Ductal, Lobular, and Medullary; Paclitaxel; Taxoids; Zoledronic Acid | 2004 |
[Multiple myeloma of the IgD-lambda type invading CNS].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Immunoglobulin D; Injections, Spinal; Interferon-alpha; Melphalan; Meningeal Neoplasms; Methotrexate; Middle Aged; Multiple Myeloma; Myeloma Proteins; Neoplasm Invasiveness; Nitrosourea Compounds; Prednisolone; Radiotherapy, Adjuvant; Thalidomide; Vincristine | 2004 |
Primary malignant melanoma of the urethra.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Diagnostic Errors; Doxorubicin; Humans; Lymph Node Excision; Male; Melanoma; Methotrexate; Neoplasm Invasiveness; Neoplasm Seeding; Penis; Prostatectomy; Urethral Neoplasms; Urinary Bladder Neoplasms; Urinary Diversion; Vinblastine | 2005 |
The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Epirubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2005 |
Isolated central nervous system blast crisis in chronic myeloid leukemia.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Bone Marrow; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Humans; Hydrocortisone; Imatinib Mesylate; Injections, Spinal; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Meninges; Methotrexate; Neoplasm Invasiveness; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Remission Induction | 2004 |
Transitional cell carcinoma of the ovary.
Topics: Abdominal Pain; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma, Transitional Cell; Cisplatin; Female; Follow-Up Studies; Humans; Immunohistochemistry; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Ovarian Neoplasms; Rare Diseases; Risk Assessment; Treatment Outcome | 2005 |
[Intra-arterial chemotherapy for invasive bladder cancer (T2-3N0M0)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Drug Administration Schedule; Female; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Radiotherapy Dosage; Urinary Bladder Neoplasms; Vinblastine | 2006 |
Squamous cell carcinoma of the bladder: a patient treated successfully with a new combined chemotherapy regimen, intraarterial nedaplatin and pirarubicin plus intravenous methotrexate and vincristine.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Doxorubicin; Drug Administration Routes; Female; Humans; Infusions, Intra-Arterial; Injections, Intravenous; Magnetic Resonance Imaging; Methotrexate; Neoplasm Invasiveness; Organoplatinum Compounds; Remission Induction; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Vincristine | 2006 |
[Cardiac infiltration as complication of cutaneous T-lymphoblastic non-Hodgkin's lymphoma].
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Heart Atria; Heart Neoplasms; Heart Ventricles; Humans; Injections, Spinal; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Radiography, Thoracic; Skin Neoplasms; Time Factors; Tomography, X-Ray Computed; Tricuspid Valve | 2007 |
[Bladder preservation by chemoradiotherapy in combination with radical TUR-Bt in muscle invasive bladder cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Middle Aged; Muscles; Neoplasm Invasiveness; Survival Rate; Transurethral Resection of Prostate; Urinary Bladder; Urinary Bladder Neoplasms | 2007 |
Background Variables for the Patients with Invasive Bladder Cancer Suitable for Bladder-preserving Therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Risk Assessment; Survival Analysis; Urinary Bladder Neoplasms | 2007 |
Muscle-invasive urothelial carcinoma of the bladder: neoadjuvant chemotherapy enables organ-preserving therapy in carefully selected patients.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystectomy; Doxorubicin; Humans; Lymphatic Metastasis; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Patient Selection; Urinary Bladder; Urinary Bladder Neoplasms; Vinblastine | 2008 |
Isolated lymphoma of the anterior visual pathway diagnosed by optic nerve biopsy.
Topics: Aged; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Biopsy; Diagnosis, Differential; Disease Progression; Fatal Outcome; Humans; Leucovorin; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Neoplasm Invasiveness; Optic Chiasm; Optic Nerve; Optic Nerve Neoplasms; Prednisone; Treatment Failure; Vision, Low; Vitamin B Complex | 2008 |
[Adjuvant chemotherapy following total cystectomy for invasive bladder cancer with bleomycin, vincristine and methotrexate].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Transitional Cell; Combined Modality Therapy; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prognosis; Urinary Bladder; Urinary Bladder Neoplasms; Vincristine | 1984 |
Methotrexate as salvage or adjunctive therapy for primary invasive carcinoma of the bladder.
Topics: Bone Neoplasms; Carcinoma, Transitional Cell; Drug Evaluation; Humans; Methotrexate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Pilot Projects; Urinary Bladder Neoplasms | 1981 |
[Pathohistologic changes after induction cytostatic therapy with methotrexate (M), bleomycin (B) and cisplatin (P)--(MBP)].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Head and Neck Neoplasms; Methotrexate; Neoplasm Invasiveness | 1982 |
Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx, and hypopharynx.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypopharynx; Male; Methotrexate; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Oropharynx; Pharyngeal Neoplasms; Vincristine | 1983 |
Invasive mole.
Topics: Choriocarcinoma; Dactinomycin; Dilatation and Curettage; Female; Humans; Hydatidiform Mole; Hydatidiform Mole, Invasive; Hysterectomy; Methotrexate; Myometrium; Neoplasm Invasiveness; Neoplasm Metastasis; Pregnancy; Trophoblasts; Uterine Neoplasms | 1982 |
Nonmetastatic and low-risk metastatic gestational trophoblastic neoplasms.
Topics: Contraception; Dactinomycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leucovorin; Methotrexate; Neoplasm Invasiveness; Neoplasm Metastasis; Pregnancy; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms | 1982 |
[Results of modified LSA2L2 therapy in children with non-Hodgkin's lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Lymphoma; Male; Methotrexate; Neoplasm Invasiveness; Prednisone; Vincristine | 1984 |
[Effects of prophylactic treatment of central nervous system leukemia in children. Analysis of CNS prophylactic treatment with cyclic high dose multichemotherapy, craniospinal irradiation, and high dose infusion of MTX].
Topics: Adolescent; Brain; Central Nervous System Diseases; Child; Child, Preschool; Female; Humans; Infant; Leukemia; Leukemia, Lymphoid; Male; Methotrexate; Neoplasm Invasiveness; Radiotherapy Dosage; Spinal Cord | 1982 |
Combined surgery and adjuvant chemotherapy with high dose methotrexate and folinic acid rescue (HDMTX-CF) for infiltrating tumours of the bladder.
Topics: Carcinoma, Transitional Cell; Drug Therapy, Combination; Humans; Leucovorin; Methotrexate; Neoplasm Invasiveness; Urinary Bladder; Urinary Bladder Neoplasms | 1981 |
Surgery and adjuvant chemotherapy with high-dose methotrexate and folinic acid rescue for infiltrating tumors of the bladder.
Topics: Carcinoma, Transitional Cell; Drug Administration Schedule; Female; Humans; Leucovorin; Male; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Urinary Bladder Neoplasms | 1981 |
[Soft tissue sarcomas in childhood (author's transl)].
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Hemangiosarcoma; Humans; Infant; Male; Methotrexate; Neoplasm Invasiveness; Prognosis; Rhabdomyosarcoma; Soft Tissue Neoplasms | 1982 |
[Intraventricular chemotherapy for treatment of meningeal dissemination from malignant neoplasms (author's transl)].
Topics: Antineoplastic Agents; Cytarabine; Hydrocortisone; Injections, Intraventricular; Leukemia; Lymphoma; Meningeal Neoplasms; Methotrexate; Neoplasm Invasiveness | 1980 |
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Nucleus; Cisplatin; Doxorubicin; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Methotrexate; Neoplasm Invasiveness; Prognosis; Urinary Bladder Neoplasms; Vinblastine | 1995 |
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Nucleus; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Pilot Projects; Prognosis; Survival Analysis; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms; Vinblastine | 1995 |
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5 year follow-up.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Follow-Up Studies; Humans; Methotrexate; Neoplasm Invasiveness; Prognosis; Urinary Bladder Neoplasms; Vinblastine | 1995 |
Hydatidiform mole with a coexistent fetus after ovulation induction.
Topics: Abortion, Induced; Adult; Anovulation; Blood Transfusion; Chorionic Gonadotropin; Female; Fetal Resorption; Humans; Hydatidiform Mole, Invasive; Methotrexate; Neoplasm Invasiveness; Ovulation Induction; Pregnancy; Pregnancy, Multiple; Remission Induction; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms | 1994 |
DNA ploidy and P-glycoprotein expression as predictive factors of response to neoadjuvant chemotherapy for invasive bladder cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Transitional Cell; Carrier Proteins; Chemotherapy, Adjuvant; Cisplatin; DNA, Neoplasm; Female; Humans; Male; Membrane Glycoproteins; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Proteins; Ploidies; Predictive Value of Tests; Remission Induction; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cause of Death; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Preoperative Care; Pulmonary Embolism; Retrospective Studies; Salvage Therapy; Survival Rate; Ureteral Obstruction; Urinary Bladder Neoplasms; Vinblastine | 1994 |
Chemotherapy combined with surgery in the treatment of gestational trophoblastic disease (GTD).
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Hydatidiform Mole; Hydroxyurea; Hysterectomy; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Pregnancy; Salvage Therapy; Thoracotomy; Treatment Outcome; Trophoblastic Neoplasms; Uterine Hemorrhage; Uterine Neoplasms; Vincristine | 1993 |
[Adjuvant chemotherapy in infiltrating bladder carcinoma. Long-term results].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1993 |
Neoadjuvant cisplatin, methotrexate and vinblastine for muscle-invasive bladder cancer: long-term followup.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Muscle, Smooth; Neoplasm Invasiveness; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1993 |
[Evaluation of intra-arterial infusion chemotherapy and radical pancreatectomy in patients with locally advanced pancreatic cancer].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Doxorubicin; Drug Administration Schedule; Fluorouracil; Humans; Infusions, Intra-Arterial; Methotrexate; Neoplasm Invasiveness; Pancreatectomy; Pancreatic Neoplasms; Survival Rate | 1993 |
Cisplatin-based neoadjuvant chemotherapy and combined resection for ethmoid sinus adenocarcinoma reaching and/or invading the skull base.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Ethmoid Sinus; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paranasal Sinus Neoplasms; Retrospective Studies; Skull Neoplasms | 1996 |
Intra-arterial chemotherapy for muscle-invasive urinary bladder cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Epirubicin; Female; Humans; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Tomography, Emission-Computed, Single-Photon; Urinary Bladder Neoplasms; Vinblastine | 1996 |
Neoadjuvant chemotherapy (MVAC) in locally invasive bladder cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Retrospective Studies; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1996 |
[The efficacy of neoadjuvant chemotherapy and morphological classification of invasive bladder cancer according to chemoresponse].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Retrospective Studies; Urinary Bladder Neoplasms; Vinblastine | 1996 |
[Long-term survivor (15 years) following central nervous system involvement in B-cell lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Humans; Lymphoma, B-Cell; Male; Mercaptopurine; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prednisolone; Survivors; Vincristine | 1996 |
[A case of gastric malignant lymphoma with perforation during chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Pancreatic Neoplasms; Prednisolone; Rupture, Spontaneous; Splenic Neoplasms; Stomach Neoplasms; Stomach Rupture; Vincristine | 1997 |
Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression.
Topics: Animals; Antimetabolites, Antineoplastic; CHO Cells; Cricetinae; Drug Resistance, Neoplasm; Female; Green Fluorescent Proteins; Liver Neoplasms, Experimental; Luminescent Proteins; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Microscopy, Fluorescence; Neoplasm Invasiveness; Transfection | 1997 |
[Bellini duct carcinoma of kidney with invasive growth pattern: a case report].
Topics: Adenocarcinoma, Papillary; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Humans; Kidney Neoplasms; Kidney Tubules, Collecting; Male; Methotrexate; Neoplasm Invasiveness; Vinblastine | 1997 |
Radical chemoradiotherapy for elderly patients with bladder carcinoma invading muscle.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Radiation; Doxorubicin; Female; Humans; Male; Methotrexate; Muscles; Neoplasm Invasiveness; Radiotherapy; Survival Analysis; Urinary Bladder Neoplasms; Vinblastine | 1997 |
[Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Muscle, Smooth; Neoplasm Invasiveness; Neoplasm Staging; Radioisotope Teletherapy; Radiotherapy, Adjuvant; Remission Induction; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 1997 |
[Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Evaluation Studies as Topic; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm, Residual; Preoperative Care; Radiotherapy, Adjuvant; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 1998 |
[Conservative treatment of infiltrating cancer of the bladder: neoadjuvant chemotherapy and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Humans; Methotrexate; Middle Aged; Neoplasm Invasiveness; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Urinary Bladder Neoplasms; Vinblastine | 1998 |
Radical transurethral resection and chemotherapy in the treatment of muscle-invasive bladder cancer: a long-term follow-up.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Disease Progression; Disease-Free Survival; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms | 1999 |
[A case report of hepatocellular carcinoma with hepatic and portal venous tumor thrombus and multiple intrahepatic metastasis who survived over 1 year after the operation with combined locoregional chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Embolization, Therapeutic; Fluorouracil; Hepatectomy; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Methotrexate; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Portal Vein | 1999 |
TP53 accumulation predicts improved survival in patients resistant to systemic cisplatin-based chemotherapy for muscle-invasive bladder cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drug Resistance, Multiple; Epirubicin; Female; Genes, p53; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Predictive Value of Tests; Prognosis; Retrospective Studies; Survival Rate; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms; Vinblastine | 1999 |
The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Disease-Free Survival; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Muscle, Smooth; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Risk Factors; Treatment Failure; Urinary Bladder Neoplasms; Vinblastine | 2000 |
A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Fluorouracil; Humans; Leucovorin; Methotrexate; Neoplasm Invasiveness; Neoplasm Metastasis; Urologic Neoplasms | 2000 |
Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Humans; Methotrexate; Multicenter Studies as Topic; Neoplasm Invasiveness; Randomized Controlled Trials as Topic; Urinary Bladder Neoplasms; Vinblastine | 2000 |
Postsurgical sequential methotrexate, fluorouracil, and leucovorin for stages 3 and 4 gastric carcinoma: A preliminary study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Fluorouracil; Gastrectomy; Humans; Leucovorin; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2000 |
Invasive bladder cancer: a single-institution experience with bladder-sparing approach.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Prognosis; Time Factors; Urinary Bladder Neoplasms; Vinblastine | 2000 |
Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cystectomy; Doxorubicin; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Randomized Controlled Trials as Topic; Reproducibility of Results; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2001 |
Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystectomy; Doxorubicin; Humans; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2001 |
Successful treatment of a persistent mole with myometrial invasion by direct injection of methotrexate.
Topics: Adult; Antimetabolites, Antineoplastic; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Hydatidiform Mole; Injections, Intralesional; Methotrexate; Myometrium; Neoplasm Invasiveness; Neoplasm, Residual; Pregnancy; Ultrasonography; Uterine Neoplasms; Vacuum Curettage | 2001 |
[Locally advanced or metastatic bladder carcinoma. Current aspects of therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Humans; Lymph Node Excision; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Randomized Controlled Trials as Topic; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 2001 |
[Clinical study on the expression level of lymphocyte function-related antigen of breast cancer patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drugs, Chinese Herbal; Female; Fluorouracil; Humans; Intercellular Adhesion Molecule-1; Lymphocyte Function-Associated Antigen-1; Lymphocytes; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness | 2000 |
Prognostic value of thymidine phosphorylase expression in breast carcinoma.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Fluorouracil; Follow-Up Studies; Humans; Life Tables; Methotrexate; Neoplasm Invasiveness; Neoplasm Proteins; Neovascularization, Pathologic; Predictive Value of Tests; Prognosis; Selective Estrogen Receptor Modulators; Survival Analysis; Tamoxifen; Thymidine Phosphorylase | 2002 |
[A patient with advanced gastric cancer surviving for more than 5 years after neoadjuvant chemotherapy and curative resection].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Duodenal Neoplasms; Female; Fluorouracil; Gastrectomy; Humans; Lymph Node Excision; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Stomach Neoplasms | 2002 |
Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Cytarabine; Female; Head and Neck Neoplasms; Humans; Hydrocortisone; Infant; Infant, Newborn; Injections, Spinal; Male; Meningeal Neoplasms; Methotrexate; Neoplasm Invasiveness; Outcome Assessment, Health Care; Prognosis; Radiation Dosage; Randomized Controlled Trials as Topic; Rhabdomyosarcoma; Survival Analysis; Treatment Outcome | 2002 |
Evaluation of the influence of systemic neoadjuvant chemotherapy on the survival of patients treated for invasive bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Preoperative Care; Retrospective Studies; Survival Analysis; Urinary Bladder Neoplasms; Vinblastine | 2002 |
Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystoscopy; Doxorubicin; Follow-Up Studies; Humans; Methotrexate; Neoplasm Invasiveness; Radiotherapy, Adjuvant; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2002 |
The effect of methotrexate on actin and invasiveness of hepatoma Morris 5123 cells in culture.
Topics: Actins; Animals; Antimetabolites, Antineoplastic; Biocompatible Materials; Carcinoma, Hepatocellular; Cell Movement; Collagen; Cytoplasm; Cytosol; Dose-Response Relationship, Drug; Drug Combinations; Laminin; Methotrexate; Microscopy, Fluorescence; Neoplasm Invasiveness; Proteoglycans; Rats; Tumor Cells, Cultured | 2001 |
The efficacy of neoadjuvant chemotherapy in invasive bladder cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Probability; Prospective Studies; Survival Rate; Treatment Outcome; Turkey; Urinary Bladder Neoplasms; Vinblastine | 2002 |
Acute renal failure associated with neoplastic disease and its treatment.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Antineoplastic Agents; Cisplatin; Female; Humans; Hypercalcemia; Kidney; Methotrexate; Multiple Myeloma; Myeloma Proteins; Neoplasm Invasiveness; Neoplasms; Radiation Injuries; Streptozocin; Ureteral Obstruction; Uric Acid; Urogenital Neoplasms | 1978 |
[Pregnancy dependent trophoblast diseases].
Topics: Choriocarcinoma; Chorionic Gonadotropin; Dactinomycin; Dilatation and Curettage; Female; Humans; Hydatidiform Mole; Hysterectomy; Methotrexate; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Pregnancy; Trophoblastic Neoplasms; Ultrasonography | 1978 |
[Breast neoplasms. Staging, therapy and after care].
Topics: Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Immunotherapy; Mastectomy; Methotrexate; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging | 1978 |
Nonresectable adenocarcinoma of the rectum assessed by MR imaging before and after chemotherapy and irradiation.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Humans; Leucovorin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Rectal Neoplasms | 1992 |
[Cyst formation following local chemotherapy of malignant brain tumor: a clinicopathological study of two cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain; Brain Neoplasms; Chemotherapy, Adjuvant; Cysts; Doxorubicin; Glioma; Humans; Infusion Pumps, Implantable; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Radiotherapy Dosage; Tomography, X-Ray Computed | 1992 |
[Neoadjuvant chemotherapy (M-VAC) for locally invasive bladder cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Urinary Bladder Neoplasms; Vinblastine | 1992 |
The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Follow-Up Studies; Humans; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Survival Analysis; Time Factors; Urinary Bladder Neoplasms; Vinblastine | 1992 |
[Study of the combined M-VAC therapy in invasive bladder cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Urinary Bladder Neoplasms; Vinblastine | 1991 |
Organ conservation in deeply invasive bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Follow-Up Studies; Humans; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1991 |
[Chemotherapy of invasive bladder cancer].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Humans; Methotrexate; Neoplasm Invasiveness; Urinary Bladder Neoplasms; Vinblastine | 1991 |
Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Survival Rate; Time Factors; Urinary Bladder Neoplasms; Vinblastine | 1990 |
Phase II trial of pre- and postoperative cisplatin, methotrexate and vinblastine in infiltrating bladder cancer: a three year experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cystectomy; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Humans; Lymph Node Excision; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Urinary Bladder Neoplasms; Vinblastine | 1990 |
Neoadjuvant M-VAC chemotherapy and partial cystectomy for treatment of locally invasive transitional cell carcinoma of the bladder.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Clinical Protocols; Combined Modality Therapy; Cystectomy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Urinary Bladder Neoplasms; Vinblastine | 1990 |
M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Muscles; Neoplasm Invasiveness; Neoplasm Staging; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1990 |
[Secondary metastasis after excision of oral squamous cancer without local recurrence].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Mouth; Mouth Neoplasms; Neck Dissection; Neoplasm Invasiveness; Picibanil; Postoperative Period; Tongue Neoplasms | 1989 |
Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Urinary Bladder Neoplasms; Vinblastine | 1989 |
New xenograft model for assessing experimental therapy of central nervous system tumors: human glioblastoma in the intrathecal compartment of the nude mouse.
Topics: Animals; Carmustine; Cell Line; Disease Models, Animal; Drug Screening Assays, Antitumor; Glioma; Humans; Injections, Intraperitoneal; Injections, Spinal; Male; Methotrexate; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplasms, Nerve Tissue; Spinal Cord; Time Factors; Transplantation, Heterologous | 1988 |
Invasive adenocarcinoma of bladder response to cisplatinum, methotrexate, and vinblastine chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Diagnosis, Differential; Humans; Lymph Nodes; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Pelvis; Urinary Bladder Neoplasms; Vinblastine | 1989 |
Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases.
Topics: Administration, Intravesical; Carcinoma, Transitional Cell; Ethoglucid; Humans; Methotrexate; Mitomycin; Mitomycins; Neoplasm Invasiveness; Neoplasm Metastasis; Prognosis; Urinary Bladder Neoplasms | 1986 |
[Combination of radio-chemotherapy for curing of childhood hematologic tumors: preventive approaches and problems on CNS involvement].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Male; Meningeal Neoplasms; Methotrexate; Neoplasm Invasiveness; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis | 1988 |
Pre-cystectomy chemotherapy in patients with muscle infiltrating bladder carcinoma. A multicentre feasibility study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Male; Methotrexate; Middle Aged; Muscle, Smooth; Neoplasm Invasiveness; Urinary Bladder; Urinary Bladder Neoplasms | 1987 |
Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma in Situ; Cell Cycle; DNA, Neoplasm; Epithelium; Evaluation Studies as Topic; Female; Flow Cytometry; Fluorouracil; Humans; Melphalan; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Thymidine; Tritium | 1986 |
Chemotherapy of invasive carcinoma of the bladder.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Humans; Lymphatic Metastasis; Methotrexate; Neoplasm Invasiveness; Urinary Bladder Neoplasms | 1985 |
[Systemic cisplatin-based chemotherapy in the treatment of advanced bladder cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Furosemide; Humans; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Urinary Bladder Neoplasms | 1985 |